You just read:

Impopharma Inc. and Breckenridge Pharmaceutical Inc. Enter Into an Asset-Purchase Agreement to Commercialize the Generic Version of a Leading Corticosteroid Product Upon FDA Approval

News provided by

Impopharma Inc.

Sep 28, 2017, 07:00 ET